TOP 30 Childhood cancer research in Memphis, Tennessee

24 results found

St. Jude Children's Research Hospital, located at 262 Danny Thomas Place in Memphis, Tennessee, is a renowned institution dedicated to finding cures for childhood cancer and other life-threatening diseases. The hospital offers a variety of services including dentistry, medical care, pharmacy services, and a store. Patients and families can benefit from a weekly lecture series featuring experts in various fields of science. Supporting St. Jude means supporting children like Mila, Kinlee, Kamryn, and Camille, who have received exceptional care and treatment at the hospital. The hospital is at the forefront of research and treatment for pediatric illnesses, providing innovative therapies and compassionate care to all patients.

The Children's Foundation Research Institute is a leading health institution located at 50 North Dunlap Street in Memphis, Tennessee, United States. Dedicated to advancing pediatric healthcare through cutting-edge research, the institute focuses on improving the lives of children through innovative treatments and therapies. With a team of renowned experts and state-of-the-art facilities, the institute is committed to making breakthroughs in children's health and providing the best possible care for young patients.

Spence and Becky Wilson Baptist Children's Hospital is a renowned healthcare facility located at 6225 Humphreys Boulevard in Memphis, Tennessee, United States. As a specialized children's hospital, it is dedicated to providing top-notch medical care to young patients in a compassionate and family-centered environment. With a team of skilled healthcare professionals and state-of-the-art facilities, the hospital offers a wide range of services to ensure the health and well-being of children in need. From advanced medical treatments to supportive care, Spence and Becky Wilson Baptist Children's Hospital is committed to making a positive impact on the lives of young patients and their families.

St. Jude Patient Care Center, located at 262 Danny Thomas Place in Memphis, Tennessee, is a leading health institution dedicated to treating children and teens with cancer, blood disorders, and other life-threatening diseases. As part of the St. Jude family, patients and their families are provided with resources and experts to help them throughout their treatment journey. The center offers a wide range of support services, from school assistance to social work, all in one convenient location. Most children at St. Jude are treated as outpatients, with educational resources available to help families care for their child away from the hospital. The institution also offers a safe online platform, the Together Community, for families facing catastrophic illnesses. St. Jude MyChart and the St. Jude app provide additional tools for families to navigate their child's care and stay informed about appointments and events.

The Kay Center, located at 262 Danny Thomas Place in Memphis, Tennessee, is a health institution dedicated to finding cures for childhood cancer. Through a weekly lecture series featuring experts in basic, translational, clinical, and population science, the center educates the public on the importance of supporting St. Jude in their mission. Quotes from parents of patients highlight the impact of the center's work, showcasing the positive outcomes for children like Mila, Kinlee, Kamryn, and Camille. St. Jude is at the forefront of childhood cancer research and treatment, utilizing advanced imaging technologies to better understand and combat these diseases. Donations are crucial to ensuring that every child, regardless of their location, has access to quality care. The center also provides language assistance services free of charge. Join the cause and help save lives by supporting the Kay Center and St. Jude.

The Eric Trump Foundation Surgery & ICU Center is a leading health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Specializing in complex and rare solid tumor surgeries, our surgeons at St. Jude are nationally recognized for their expertise. As the only hospital dedicated solely to children that has been named a Comprehensive Cancer Center by the National Cancer Institute, we are committed to providing the best care for your child. Our Brain Tumor Treatment Program focuses on treating challenging pediatric brain tumors in children and young adults, while our Solid Tumor Treatment Program offers a dedicated team of physicians and researchers working towards finding cures for solid tumors. We are also at the forefront of improving outcomes for children with leukemia and lymphoma, including difficult-to-treat cases.

St. Jude Living Well Center is a state-of-the-art gym and health facility located at 262 Danny Thomas Place in Memphis, Tennessee, United States. As part of St. Jude's commitment to employee wellness, the Living Well Center focuses on five core areas: Getting Active, Eating Healthy, Preventing Illness/Injury, Balancing Work/Family, and Coping with Stress. Research has shown that workplace wellness programs lead to more productive employees, and since implementing the program, there has been a noticeable increase in motivation and positive attitudes among staff members. The facility offers a variety of fitness equipment and classes, providing employees with the opportunity to prioritize their health and well-being. In addition to the wellness program, St. Jude offers rewarding job opportunities in scientific research, clinical care, and business operations. Employees can also take advantage of excellent benefits, including life and health insurance plans, retirement savings plans, and time off programs. The institution is a premier academic research center, offering faculty positions in basic science, translational research, and clinical care.

Dr. Kevin Krull is a healthcare institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Dr. Krull is a doctor specializing in neurocognitive and psychosocial problems after Hodgkin lymphoma. He holds a MS and PhD from Florida State University and has published numerous research papers on childhood cancer survivors. His work focuses on modifiable risk factors for neurocognitive impairment and the impact of chemotherapy on long-term neurocognitive outcomes. Dr. Krull is a senior author on many publications in prestigious journals such as Blood, JAMA Oncology, and the Journal of Clinical Oncology. His research has contributed significantly to the understanding of neurocognitive outcomes in survivors of pediatric cancer.

Located at 262 Danny Thomas Place in Memphis, Tennessee, the St. Jude Graduate School of Biomedical Sciences is an exceptional academic institution affiliated with the renowned St. Jude Children’s Research Hospital. Offering degree programs in biomedical sciences, this school provides a unique opportunity for students to engage in world-class research and make a difference in the field of pediatric cancer and childhood disease. With mentorship from distinguished faculty and access to exceptional resources, students at St. Jude Graduate School of Biomedical Sciences receive a top-tier education that prepares them for successful careers in the scientific community. Authorized by the Tennessee Higher Education Commission, this institution is committed to providing a high-quality educational experience for all students. Visit their website for more information on programs and job placement opportunities.

Aditi Bagchi is a renowned health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Specializing in pediatric neuro-oncology, the institution offers a range of services to infants and young children with complex medical conditions. Dr. Aditi Bagchi holds a PhD in Cell and Molecular Biology and has completed various fellowships and residencies in prestigious institutions across the United States. Her groundbreaking research on rare cases of medulloblastoma and high-grade glioma has been published in leading medical journals. The institution also provides multilingual assistance services free of charge, ensuring that all patients receive the care and support they need.

Dr. Lillian Guenther's institution, located at 262 Danny Thomas Place in Memphis, Tennessee, is dedicated to researching and treating challenging cancers, with a specific focus on osteosarcoma, the most common malignant bone tumor in children. The laboratory at this institution examines the genetic drivers behind osteosarcoma using genome-scale screening techniques and diverse models. Dr. Guenther and her team are investigating new combination approaches to treatment based on their understanding of osteosarcoma's genetic landscape. Their goal is to uncover highly effective therapeutic strategies for children with this aggressive disease. The Guenther Lab Team consists of individuals performing clinical trials work in sarcomas and solid tumors, with a strong focus on understanding the complex genome of osteosarcoma. Dr. Guenther's research uses genome-scale CRISPR screening to examine critical non-mutated genes in the osteosarcoma cancer genome, with a specific focus on the DNA damage response cascade. By investigating promising osteosarcoma dependency genes, including those involved in DNA damage repair, Dr. Guenther aims to find ways to harness cancer cell vulnerabilities that will transform osteosarcoma treatment.

Dr. Jeremy Slone is a renowned health institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Jeremy Slone holds a BS in Biology, Chemistry, and History from Mount Vernon Nazarene University in Ohio, an MD from Wright State University Boonshoft School of Medicine in Ohio, and completed his Internship/Residency in General Pediatrics at Phoenix Children’s Hospital in Arizona. He further pursued a Fellowship in Pediatric Hematology-Oncology at Vanderbilt University in Tennessee, and also holds an MPH in Epidemiology from Vanderbilt University. Dr. Jeremy Slone has been involved in various research studies and publications, focusing on pediatric cancers and HIV-related conditions in Africa. His expertise and dedication to improving healthcare for children in low-income countries have been recognized globally. Dr. Jeremy Slone and his team are committed to providing the best possible care for children with cancer, even during challenging times such as the COVID-19 crisis.

Charles Roberts is a renowned doctor and health institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. The institution is led by Dr. Charles Roberts, who holds an MD and PhD from Washington University in St. Louis, Missouri. With extensive experience in the field of pediatric oncology, Dr. Roberts completed his internship and residency at Children's Hospital in Boston, Massachusetts, and pursued further training at Dana-Farber Cancer Institute. The institution specializes in research and treatment of various pediatric cancers, with a focus on rhabdoid tumors. Dr. Roberts and his team have published numerous groundbreaking studies in prestigious journals such as Nature Genetics and Cancer Research, highlighting their expertise in the field. The institution offers cutting-edge treatments and therapies for pediatric cancer patients, with a particular emphasis on personalized medicine approaches.

Stephanie Dixon is a renowned institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Specializing in the field of health and medicine, Stephanie Dixon has conducted groundbreaking research on specific causes of excess late mortality among survivors of childhood cancer. Led by Dr. Stephanie Dixon, the institution has published numerous studies on genetic risk factors for severe obesity in adult survivors of childhood cancer, as well as functional outcomes and social attainment in Asian/Pacific Islander childhood cancer survivors in the United States. Additionally, Stephanie Dixon has explored the impact of risk-stratified therapy on health status in survivors of childhood Acute Lymphoblastic Leukemia, as well as associations between chemotherapy, chronic conditions, and neurocognitive impairment in ALL survivors. With a focus on improving patient outcomes, Stephanie Dixon has also been involved in initiatives to enhance patient handoffs and transitions through the implementation of I-PASS across multiple settings. For individuals in need of language assistance, free services are available by calling 1-866-278-5833 (TTY: 1-901-595-1040).

Dr. Melissa Hudson is a renowned health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Dr. Hudson is a highly qualified doctor with a Bachelor of Science from Texas A & M University and a Doctor of Medicine from the University of Texas Medical School at Houston. The institution specializes in providing comprehensive care for pediatric cancer survivors, with a focus on addressing premature aging and genetic risk factors for obesity and other health issues. Dr. Hudson's research has been published in prestigious medical journals, highlighting her expertise in the field. The institution offers personalized care and support for survivors of childhood cancer, with a strong emphasis on long-term health outcomes and quality of life. Patients can expect compassionate and evidence-based care at Dr. Melissa Hudson's institution.

Aimee Talleur is a health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Dr. Aimee Talleur holds a BA from Union College in Schenectady, NY, an MD from State University of New York Upstate Medical University in Syracuse, NY, completed a Pediatric Residency at Children’s National Medical Center in Washington DC, and a Pediatric Hematology-Oncology Fellowship as well as a Pediatric Bone Marrow Transplantation and Cellular Therapy Fellowship at St. Jude Children’s Research Hospital. The institution specializes in pediatric hematology-oncology and offers treatments such as CD19-CAR T-cell therapy for patients with B-ALL. Research conducted at the institution includes studies on the development and effectiveness of CAR T-cell therapy, as well as the impact of disease burden on treatment outcomes. Additional services provided by the institution include diagnostic evaluation and treatment for myeloid malignancies, hematopoietic cell transplants, and adoptive cell therapy. Multilingual assistance services are available for non-English speaking patients. For more information, contact 1-866-278-5833 (TTY: 1-901-595-1040).

Dr. Alia Zaidi is a healthcare institution located at 262 Danny Thomas Place in Memphis, Tennessee. Dr. Zaidi is a highly qualified doctor with degrees from prestigious institutions such as the University of Punjab in Lahore, Pakistan, and the Royal Colleges of Physicians in the United Kingdom. Specializing in pediatric oncology, Dr. Zaidi has conducted research and published papers on childhood cancer survival, public-private partnerships in pediatric cancer care, and the management of concurrent pregnancy and acute lymphoblastic malignancy in teenaged patients. The institution offers language assistance services free of charge to patients who speak languages other than English. For more information or to schedule an appointment, please call 1-866-278-5833 (TTY: 1-901-595-1040).

Dr. Sara Helmig is a renowned doctor specializing in pediatric hematology/oncology, located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Helmig has an impressive educational background, including a BS from University Notre Dame in South Bend, Indiana, an MD from Tulane University School of Medicine in New Orleans, Louisiana, and completed her Pediatric Residency/Internship and Pediatric Hematology/Oncology Fellowship at the University of Texas Southwestern Medical Center in Dallas, Texas. Dr. Helmig's research has been published in reputable scientific journals, such as Sci Rep, demonstrating her expertise in the field. Additionally, the institution offers assistance services in multiple languages free of charge, ensuring that all patients receive the care they need. For more information or to schedule an appointment, please call 1-866-278-5833 (TTY: 1-901-595-1040).

Dr. Matthew Ehrhardt is a renowned health institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Specializing in pediatric Hodgkin lymphoma treatment and late effects guidelines, Dr. Ehrhardt and his team are dedicated to providing comprehensive and personalized care to their patients. With a focus on integrating treatment and guidelines to ensure the best outcomes for their patients, the institution is at the forefront of research and innovation in the field of pediatric oncology. Their commitment to improving the long-term health and well-being of childhood cancer survivors is evident in their extensive research and publications. From optimizing cardiovascular care to identifying vulnerable groups at key medical transitions, Dr. Matthew Ehrhardt and his team are dedicated to providing high-quality care to their patients.

Dr. Deena Levine is a healthcare institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Levine has an extensive educational background, including a BA from Lehigh University in Pennsylvania, an MD from Drexel University College of Medicine in Philadelphia, and completed her residency at the University of Medicine and Dentistry of New Jersey in Newark. She also completed a fellowship at Johns Hopkins - National Institute of Health in Maryland. Dr. Levine specializes in pediatric oncology and palliative care, with a focus on meeting the informational needs of cancer patients and their families. She has published numerous research papers on topics such as end-of-life care, palliative care integration, and communication with children and families facing cancer. Dr. Levine and her team strive to provide comprehensive and compassionate care to all their patients. Assistance services are available for non-English speakers.

Swati Naik is a renowned doctor specializing in pediatric hematology and oncology, located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Naik received her MBBS from Deccan College of Medical Sciences in Hyderabad, India, and completed her Pediatric Residency at SUNY Downstate Medical Center in Brooklyn, New York. She further pursued a Pediatric Hematology and Oncology Fellowship at Baylor College of Medicine in Houston, Texas, as well as a Hematopoietic Stem Cell Transplant Fellowship at the same institution. Dr. Naik has conducted extensive research and published numerous articles in prestigious medical journals, focusing on topics such as BK virus epidemiology, leukemia-specific donor T cells, and immune monitoring in transplant recipients. She is dedicated to providing high-quality care to her patients and has a strong background in treating pediatric patients with hematologic and oncologic disorders.

Dr. Gregory Armstrong is a health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. Dr. Armstrong holds a BS from Samford University (1995), MD from the University of Alabama School of Medicine (1999), and an MS from the University of Pennsylvania in Clinical Epidemiology (2006). The institution specializes in various research studies related to cancer survivors, childhood cancer, and long-term health outcomes. Dr. Armstrong has been involved in numerous publications focusing on the health benefits and cost-effectiveness of cancer screening guidelines, financial hardship in adult survivors of childhood cancer, and the emotional and physical health consequences of cancer survivorship. The institution also conducts randomized controlled trials to advance survivors' knowledge of skin cancer surveillance after childhood cancer. With a focus on improving the health outcomes of cancer survivors, Dr. Gregory Armstrong's institution plays a crucial role in research and care for individuals affected by cancer.

Clifford Takemoto is a health institution located at 262 Danny Thomas Place, Memphis, Tennessee, United States. The institution is a doctor specializing in pediatric hematology/oncology. Dr. Takemoto obtained a BS in Biochemistry from the University of California at Davis, an MD in Medicine from the University of California at Irvine, and completed internships and residencies at The Children’s Hospital of Los Angeles. Dr. Takemoto has also conducted research in hematology/oncology at various institutions including the National Children’s Medical Research Center in Tokyo, Japan, and the Boston Children’s Hospital/Dana-Farber Cancer Institute in Boston. The institution has published numerous research articles in reputable medical journals on topics related to sickle cell disease, thrombocytopenia, and other pediatric hematological conditions. Dr. Takemoto is known for his expertise in pediatric hematology/oncology and has contributed significantly to the field through his research and clinical practice.

St. Jude Global Pediatric Medicine, located at 262 Danny Thomas Place in Memphis, Tennessee, is a leading institution in the field of global health. With a focus on providing quality care to children with cancer in low- and middle-income countries, St. Jude Global Pediatric Medicine is dedicated to changing the devastating statistic of high mortality rates in these regions. The Department of Global Pediatric Medicine at St. Jude Children's Research Hospital brings together experts in international medicine, epidemiology, health economics, and health policy to collaborate and accelerate progress in the fight against childhood cancer, blood disorders, and other life-threatening illnesses. Their goal is to ensure that all children, regardless of their location, have access to the care they need.